312 results on '"Marques, Tiago Reis"'
Search Results
2. Genetic variants associated with longitudinal changes in brain structure across the lifespan
3. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A
4. Effects of copy number variations on brain structure and risk for psychiatric illness: Large‐scale studies from the ENIGMA working groups on CNVs
5. Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers
6. Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia
7. Neurophysiological and psychosocial mechanisms of fibromyalgia: A comprehensive review and call for an integrative model
8. Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study
9. The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia
10. Antipsychotics, versatility in action
11. Reply to ‘Imbalance of threat and soothing systems in fibromyalgia: rephrasing an established mechanistic model?’
12. Reply to: Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia
13. Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study
14. Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper
15. Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function
16. GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513
17. Beyond the Global Brain Differences:Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers
18. The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis
19. The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study
20. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
21. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia
22. Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia
23. Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies
24. Cortisol awakening response is decreased in patients with first-episode psychosis and increased in healthy controls with a history of severe childhood abuse
25. Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis
26. Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study.
27. Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction.
28. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of Synaptic Vesicle Glycoprotein 2A
29. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme
30. 5. Effects of Sustained D2 Receptors Blockade on Brain Structure and Function in Healthy Volunteers
31. Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia
32. Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction
33. Novel Approaches for Treating Psychotic Disorders
34. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
35. Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia
36. Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia
37. rephrasing an established mechanistic model?’
38. The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia
39. How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses
40. Clinical utility of magnetic resonance imaging in first-episode psychosis
41. Magnetic resonance imaging in first-episode psychosis
42. Connectomic correlates of response to treatment in first-episode psychosis
43. Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study
44. sj-docx-1-jop-10.1177_02698811221122031 – Supplemental material for The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia
45. Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First Episode
46. Dopamine, Striatum, Antipsychotics, and Questions About Weight Gain
47. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment
48. Obsessive–compulsive disorder as a visual processing impairment
49. Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study.
50. The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.